Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Leuk Lymphoma. 2015 Feb 9;56(8):2365–2372. doi: 10.3109/10428194.2014.994206

Table 2.

Univariate survival analysis of relevant clinicopathologic prognostic factors

Event-Free Survival
Comparison HR 95% CI P-Value
FLIPI Intermediate vs Low
High vs Low
3.37
4.00
1.49–7.63
1.81–8.80
0.002
Stage IV vs I–III 2.77 1.54–5.00 <0.001
Grade IIIa vs I–II 0.60 0.33–1.09 0.09
Age at diagnosis (continuous) 1 Year Increase 0.98 0.96–1.01 0.18
R-maintenance No vs Yes 1.8 0.94–3.51 0.08